Wolk is an international medtech scale-up dedicated to fall prevention and fall impact reduction for the elderly. We are rapidly scaling our proprietary solution: Wolk. The hip airbag, with breakthrough technology to enhance safety, while reducing healthcare costs and alleviating workload pressures in the sector. Driven by our mission to safeguard 100 million people worldwide, we are expanding into AI-driven fall prediction. Our solutions help retain mobility, vitality, and independence - ensuring people can live safely and carefree.
https://www.wolkairbag.com
Den Haag
Aantal werknemers:
10
Health & Science, Digital Health, Medical Devices
B2B, B2C, B2B2C
Scaling Stage
Demographic changes are increasingly placing the healthcare system under immense pressure (exploding demand for care versus cost cuts and a lack of care professionals). As a result seniors are forced into longer independent living which comes with an increase in fall incidences which in turn leads to an increase in healthcare costs & additional workload for care professionals.
WOLK offers a unique combination of state-of-the-art hardware & software that is proven to prevent falls (increase in wearer self-confidence) and in case of a fall reduces the risk of hip fracture by 95%. This leads to an annual cost savings potential of €627M and an annual savings in care hours of 1,9M hours in Netherlands alone.
Mark Berkhout (CEO), https://www.linkedin.com/in/markberkhout1/ Jeroen van der Heijden (CCO), https://www.linkedin.com/in/jeroenvanderheijden2/ Matthijs Wiegant (COO), https://www.linkedin.com/in/matthijswiegant/ Henry Rodenburgh (Head of Tech), https://www.linkedin.com/in/henryr/
Wolk is sold in B2B channels (nursing homes and home care organizations) for use by clients in care. Moreover Wolk is sold direct to consumer (B2C) to clients living independently.
Wolk has a stable and monthly growing business in the B2B channels (nursing homes and home care organizations) based on a subscription model currently serving 80 customers (500 care homes) with a total MRR of around €100K/month. The total B2B market has 150 customers serving 80% of clients. Following our organic growth of +5 new contracts per quarter, we forecast to reach 120 customers by Q1/2027. On top of this we plan to accelerate our growth through a B2C selling model to reach independently living clients. H1/2025 we are investing learning money in optimizing our consumer activation through a performance marketing model, driving awareness/lead generating/conversion through the funnel. We see strong traction after 6 weeks in the pilot and will continue our learning phase until June, subsequently scaling up B2C investments to accelerate growth. By end 2026 we forecast €4,4M revenue, of which €3,3M recurrent through subscriptions.
- €1,03 MM revenue (of which €1,03 M ARR); GM% 69% - 80 B2B customers, 97% customer retention, 5 new customers / quarter - LTV / CAC (B2B): 7.0 / LTV / CAC (B2C): 4.3
Minimaal gezocht:
1750000
Pre-money valuation:
10000000
Financieringsinstrument:
Equity
Wolk
Demographic changes are increasingly placing the healthcare system under immense pressure (exploding demand for care versus cost cuts and a lack of care professionals). As a result seniors are forced into longer independent living which comes with an increase in fall incidences which in turn leads to an increase in healthcare costs & additional workload for care professionals.
WOLK offers a unique combination of state-of-the-art hardware & software that is proven to prevent falls (increase in wearer self-confidence) and in case of a fall reduces the risk of hip fracture by 95%. This leads to an annual cost savings potential of €627M and an annual savings in care hours of 1,9M hours in Netherlands alone.
WOLK offers a unique combination of state-of-the-art hardware & software. The device itself measures the biomechanical movement of its wearer 500x/second. The sophisticated fall-detection algorithm recognizes the start of a fall based on data mileage of 500.000 wearing days and 5.000 falls. It then triggers the airbag within 0.1 seconds and protects the hip well before the wearer hits the floor. The unique algorithm and wearer mileage results in an accuracy and 95% efficacy, making Wolk stand out miles ahead of any competitor.
Mark Berkhout (CEO), https://www.linkedin.com/in/markberkhout1/ Jeroen van der Heijden (CCO), https://www.linkedin.com/in/jeroenvanderheijden2/ Matthijs Wiegant (COO), https://www.linkedin.com/in/matthijswiegant/ Henry Rodenburgh (Head of Tech), https://www.linkedin.com/in/henryr/
Health & Science, Digital Health, Medical Devices
Medical Technology
Wolk is sold in B2B channels (nursing homes and home care organizations) for use by clients in care. Moreover Wolk is sold direct to consumer (B2C) to clients living independently.
Wolk has 3 direct competitors worldwide; - Tango belt (USA) – in study phase, currently has a data mileage of 200.000 wearing hours - Hip Guard (FR) – core competence is sports airbags (bycicles, motorcycles, skiing, horseback). Their elderly product is not accurate - Indienov (FR) – exclusive sales on Amazon.fr, neither sales numbers nor reviews available
- €1,03 MM revenue (of which €1,03 M ARR); GM% 69% - 80 B2B customers, 97% customer retention, 5 new customers / quarter - LTV / CAC (B2B): 7.0 / LTV / CAC (B2C): 4.3
- Revenue: € 4.4M of which € 2.2M ARR - GM%: 72% - EBITDA: -2%
- Since founding Wolk B.V. 12 years ago, we’ve dedicated the first six years to developing our core technology and product, followed by five years of relentless refinement to eliminate imperfections and ensure a stable, reliable solution. - Today, we have fully de-risked our product, technology, business model, B2B sales strategy, as well as all operational activities. - Market entry by new (copy-cat) players can be a risk. We plan to mitigate this risk through further tech development, moving from a device/data company to an AI-enabled fall prediction data provider
Company buyout, Other
1750000
2000000
Equity
10000000
- JGMS Holding: 50% - Current management: 25% - Founders: 8,33% - Seed investors: 16,67%
Arnoud Aalbersberg, Bart Jansen, Marko Dobroschelski
I'm looking for a lead investor
- 41% Marketing €820K, of which 80% B2C campaigns (awareness/lead gen.) - 26% Staff €520K, of which 60% sales FTEs - 14%Tech (€280K), ERP, dashboard update, tech roadmap - 9% Working capital (€180K) - 9% reserve (€180K)
Yes
Wolk has a stable and monthly growing business in the B2B channels (nursing homes and home care organizations) based on a subscription model currently serving 80 customers (500 care homes) with a total MRR of around €100K/month. The total B2B market has 150 customers serving 80% of clients. Following our organic growth of +5 new contracts per quarter, we forecast to reach 120 customers by Q1/2027. On top of this we plan to accelerate our growth through a B2C selling model to reach independently living clients. H1/2025 we are investing learning money in optimizing our consumer activation through a performance marketing model, driving awareness/lead generating/conversion through the funnel. We see strong traction after 6 weeks in the pilot and will continue our learning phase until June, subsequently scaling up B2C investments to accelerate growth. By end 2026 we forecast €4,4M revenue, of which €3,3M recurrent through subscriptions.
- B2B: LTV €100.000, CAC €15.000. LTV/CAC: 7.0 - B2C: LTV € €850, CAC €200, LTV/CAC: 4.3 - Payroll: current €61K/mth, per 1/7/25 (post-money): €116K/month (+5 FTE)
Organic EBITDA break-even per May/2026 (revenue €143K, GP €103K, OPEX €92K, EBITDA €2K
4200000
[Annual revenue in 2023, 834235] [Annual revenue in 2024, 1046573] [Annual revenue in 2025 (YTD), 1715746] [Annual revenue in 2025 (FC), 1715746] [Annual revenue in 2026 (FC), 4388622]
- Sales FC: 2025: €1,7MM (80% ARR), 2026: €4,3MM (75% ARR), 2027: €6,6MM (80% ARR) - Organic (pre-money) break-even per May/2026; post-money break-even per August/2026
97000
40000
4
195000
© 2021 Investormatch Capital BV
